src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js?client=ca-pub-8050569412065003" crossorigin="anonymous">[/script]

Eli Lilly (LLY) earnings Q1 2025 newsthirst.

Eli Lilly on Thursday reported first-quarter revenue and earnings that topped estimates as demand for its weight loss and diabetes drugs soared, but lowered its full-year profit guidance due to charges related to a recent cancer treatment deal. The pharmaceutical giant now expects its adjusted fiscal 2025 earnings to come in between $20.78 and $22.28…

Read More

Novo Nordisk shares plunge 20% after disappointing trial results; Lilly jumps newsthirst.

Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy. Hollie Adams | Reuters Shares of Danish pharmaceutical giant Novo Nordisk plummeted roughly 20% on Friday after reporting results in a late-stage trial for its experimental CagriSema weight loss drug that missed expectations. The maker of the wildly popular Wegovy obesity…

Read More